CN116874643A - 一种木聚糖钙络合物及其在抗氧化产品中的应用 - Google Patents
一种木聚糖钙络合物及其在抗氧化产品中的应用 Download PDFInfo
- Publication number
- CN116874643A CN116874643A CN202310608567.6A CN202310608567A CN116874643A CN 116874643 A CN116874643 A CN 116874643A CN 202310608567 A CN202310608567 A CN 202310608567A CN 116874643 A CN116874643 A CN 116874643A
- Authority
- CN
- China
- Prior art keywords
- xylan
- calcium
- calcium complex
- application
- distilled water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001221 xylan Polymers 0.000 title claims abstract description 65
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 63
- 239000011575 calcium Substances 0.000 title claims abstract description 63
- 150000004823 xylans Chemical class 0.000 title claims abstract description 60
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 56
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 14
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000012153 distilled water Substances 0.000 claims abstract description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 18
- 239000000047 product Substances 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 13
- 238000006243 chemical reaction Methods 0.000 claims abstract description 11
- 230000036541 health Effects 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims abstract description 7
- 235000016709 nutrition Nutrition 0.000 claims abstract description 7
- 230000035764 nutrition Effects 0.000 claims abstract description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 6
- 239000002244 precipitate Substances 0.000 claims abstract description 6
- 230000001376 precipitating effect Effects 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 6
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 claims description 8
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000007902 hard capsule Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- -1 DPPH free radical Chemical class 0.000 abstract description 15
- 235000019441 ethanol Nutrition 0.000 abstract description 10
- 238000002390 rotary evaporation Methods 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 2
- 238000002835 absorbance Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 230000002292 Radical scavenging effect Effects 0.000 description 8
- 230000007760 free radical scavenging Effects 0.000 description 8
- 239000000523 sample Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- 230000002000 scavenging effect Effects 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 4
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 4
- 229940069978 calcium supplement Drugs 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- HEILIGJNYTWOHU-UHFFFAOYSA-N ethanol 2-hydroxybenzoic acid Chemical compound CCO.OC(=O)C1=CC=CC=C1O HEILIGJNYTWOHU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0057—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Xylans, i.e. xylosaccharide, e.g. arabinoxylan, arabinofuronan, pentosans; (beta-1,3)(beta-1,4)-D-Xylans, e.g. rhodymenans; Hemicellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种木聚糖钙络合物及其在抗氧化产品中的应用,属于保健食品和药物研究领域。该木聚糖钙络合物通过以下方法制备得到:将200 mg木聚糖溶于100 mL蒸馏水中,加入1.1 g CaCl2,用0.1 mol/L NaOH溶液调节pH至10.0,60℃反应90 min。反应结束后,浓缩,醇沉12 h,4000 r/min离心10 min,取沉淀用无水乙醇洗去氯离子,旋转蒸发除去乙醇。蒸馏水透析24 h,浓缩,冷冻干燥得到木聚糖钙络合物。本发明还涉及木聚糖钙络合物在制备抗氧化产品中应用,包括在清除DPPH自由基、羟基自由基、ABTS自由基的营养品、保健品和药物中的应用。
Description
技术领域
本发明涉及一种木聚糖钙络合物的制备方法及其在抗氧化产品中的应用,属于保健食品和药物研究领域。
背景技术
木聚糖是植物半纤维素的主要成分,天然来源的木聚糖具有抗氧化、抗肿瘤、降血糖、降血脂、益生元等多种生物活性,在健康食品和药品领域具有潜在的营养和药学效果。木聚糖骨架上有许多羟基,这些羟基可以通过化学修饰连接其他基团来调整木聚糖的性质和生物活性。
钙在细胞代谢、心脏功能等机体代谢中起着重要作用,钙缺乏会引起一系列疾病。我国现有的补钙剂大多是无机碳酸钙类,但是,由于肠道内的弱碱性环境,这些补钙剂容易形成不溶盐,影响了钙的吸收和生物利用度。因此开发能够适应胃肠道环境,易于吸收且含钙量高的补钙剂成为亟待解决的问题。
天然植物多糖与金属离子的络合物是目前临床上广泛应用的新型高效营养强化剂,这种稳定的络合物溶解度高,容易被小肠黏膜细胞吸收,同时能够减少游离金属离子对胃肠黏膜的刺激作用,并且当金属离子释放之后,多糖配体能够继续发挥其生物活性功能。
有关木聚糖钙络合物的制备及抗氧化活性研究至今未见国内外文献报道。因此,本发明将木聚糖骨架上的羟基与钙螯合形成络合物,比较不同制备条件对络合物钙含量的影响,确定最佳条件下制备的木聚糖钙络合物,研究其体外抗氧化活性,为木聚糖钙络合物在食品、医药领域的应用提供参考依据。
发明内容
本发明的目的是提供一种钙含量较高的木聚糖钙络合物的制备方法,该木聚糖钙络合物具有抗氧化作用。
本发明通过以下技术方案达到上述目的:
一种具有提高抗氧化活性的木聚糖钙络合物的制备方法,具体包括:将200 mg木聚糖溶于100 mL蒸馏水中,加入1.1 g CaCl2,用0.1 mol/L NaOH溶液调节pH至10.0,在60℃下反应90 min。反应结束后,浓缩,醇沉12 h,4000 r/min离心10 min取其沉淀,用无水乙醇洗涤至滤液中没有氯离子被检出,加入适量蒸馏水,旋转蒸发除去乙醇。蒸馏水透析24h,浓缩,冷冻干燥得到木聚糖钙络合物(Xyl-Ca)。
本发明还要求保护所述的木聚糖钙络合物在营养品、保健品和药物中的应用,包括以下3个方面。
(1)木聚糖钙络合物在制备清除DPPH自由基营养品、保健品和药物中的应用。
(2)木聚糖钙络合物在制备清除羟基自由基营养品、保健品和药物中的应用。
(3)木聚糖钙络合物在制备清除ABTS自由基营养品、保健品和药物中的应用。
本发明的有益效果在于:将人工合成的木聚糖络合物用于体外抗氧化活性实验,获得木聚糖钙络合物抗氧化的实验结果,为木聚糖钙络合物在食品、医药领域的应用提供参考依据。
附图说明
图1为实施所述反应物质量比对木聚糖钙络合物钙含量的影响
图2为实施所述反应时间对木聚糖钙络合物钙含量的影响
图3为实施所述反应温度对木聚糖钙络合物钙含量的影响
图4为实施所述反应体系pH对木聚糖钙络合物钙含量的影响
图5为不同实施例组木聚糖钙络合物对DPPH自由基的清除率的影响
图6为实施例2下不同浓度木聚糖钙络合物对DPPH自由基的清除率
图7为实施例2下不同浓度木聚糖钙络合物对羟基自由基的清除率
图8为实施例2下不同浓度木聚糖钙络合物对ABTS自由基的清除率
具体实施方式
为更好地理解本发明,下面结合具体实施例来进一步描述本发明,但是实施例仅是范例,并不对本发明的范围构成任何限制。除非特别说明,本发明采用的试剂、方法和设备均为本技术领域常规试剂、方法和设备。
实施例1
将200 mg木聚糖溶于100 mL蒸馏水中,加入1.0 g CaCl2,用0.1 mol/L NaOH溶液调节pH至9.0,在50 ℃下反应60 min。反应结束后,浓缩,醇沉12 h,4000 r/min离心10 min取其沉淀,用无水乙醇洗涤至滤液中没有氯离子被检出,加入适量蒸馏水,旋转蒸发除去乙醇。蒸馏水透析24 h,浓缩,冷冻干燥得到木聚糖钙络合物。
实施例2
将200 mg木聚糖溶于100 mL蒸馏水中,加入1.1 g CaCl2,用0.1 mol/L NaOH溶液调节pH至10.0,在60 ℃下反应90 min。反应结束后,浓缩,醇沉12 h,4000 r/min离心10min取其沉淀,用无水乙醇洗涤至滤液中没有氯离子被检出,加入适量蒸馏水,旋转蒸发除去乙醇。蒸馏水透析24 h,浓缩,冷冻干燥得到木聚糖钙络合物。
实施例3
将200 mg木聚糖溶于100 mL蒸馏水中,加入1.2 g CaCl2,用0.1 mol/L NaOH溶液调节pH至10.0,在70 ℃下反应120 min。反应结束后,浓缩,醇沉12 h,4000 r/min离心10min取其沉淀,用无水乙醇洗涤至滤液中没有氯离子被检出,加入适量蒸馏水,旋转蒸发除去乙醇。蒸馏水透析24 h,浓缩,冷冻干燥得到木聚糖钙络合物。
实施例4:木聚糖钙络合物的抗氧化活性
针对实施例1-3得到的木聚糖钙络合物的活性应用,进行了体外抗氧化活性实验,具体如下:
1、木聚糖钙络合物对DPPH自由基清除作用
取2.0 mL样品溶液,加入2.0 mL,0.04 mg/mL DPPH溶液(无水乙醇为溶剂),混匀后室温下避光反应30 min,在波长517 nm处测定吸光度,以Vc作为阳性对照,无水乙醇作为空白对照。DPPH自由基清除率计算公式如下:
式中:Ai为样品的吸光度值;Aj为样品本底液的吸光度值;Ac为空白对照的吸光度值。
分别测定实施例1-3制备的木聚糖钙提取物对DPPH自由基的清除作用,结果如图5,实施例1-3制备的木聚糖钙络合物对DPPH自由基有一定的清除作用,清除率最高为33.91%(实施例2制得),最低为21.75%(实施例1制得)。结果表明本发明制备的木聚糖钙络合物具有良好的DPPH自由基清除作用。
选取木聚糖钙和实例2制备的木聚糖钙,研究不同浓度的木聚糖和木聚糖钙对DPPH自由基清除作用,结果如图6。结果表明,在0.1 ~ 3.2 mg/mL范围内,Xyl和Xyl-Ca具有一定的DPPH自由基清除能力,且呈浓度依赖性,Xyl-Ca的DPPH自由基清除能力明显高于Xyl。
2、木聚糖钙络合物对羟基自由基清除作用
分别取1 mL 9 mmol/L FeSO4与9 mmol/L水杨酸-乙醇溶液于试管中,混匀后加入1 mL样品溶液,加入1 mL 8.8 mmol/L H2O2溶液,立即启动反应,并置于37 ℃恒温水浴锅中反应30 min,冷却至室温,在510 nm下测定吸光度,以Vc作为阳性对照,蒸馏水作为空白对照。羟基自由基清除率计算公式如下:
式中:A1为空白对照的吸光度值;A2为样品液的吸光度值;A3为样品本底液的吸光度值。
选取木聚糖钙和实例2制备的木聚糖钙,研究不同浓度的木聚糖和木聚糖钙对羟基自由基清除作用,结果如图7。结果表明,在0.1 ~ 3.2 mg/mL范围内,Xyl和Xyl-Ca具有一定的羟基自由基清除能力,且呈浓度依赖性,Xyl-Ca的羟基自由基清除能力略高于Xyl。
3、木聚糖钙络合物对ABTS自由基清除作用
将7 mmol/L ABTS溶液与2.45 mmol/L过硫酸钾1:1混合,避光静置12~16 h,使用前用去离子水稀释,使其在734 nm吸光度为0.70±0.02。取20 μL样品溶液加入180 μLABTS稀释液,振摇均匀后避光反应10 min,于734 nm测定吸光度,以Vc作为阳性对照,蒸馏水作为空白对照。ABTS自由基清除率计算公式如下:
式中:A0为空白对照的吸光度值;A1为样品液的吸光度值;A2为样品本底液的吸光度值。
选取木聚糖钙和实例2制备的木聚糖钙,研究不同浓度的木聚糖和木聚糖钙对羟基自由基清除作用,结果如图8。结果表明,在0.1 ~ 3.2 mg/mL范围内,Xyl和Xyl-Ca具有一定的ABTS自由基清除能力,且呈浓度依赖性,Xyl-Ca的ABTS自由基清除能力明显高于Xyl。
Claims (2)
1.一种木聚糖钙络合物及其在抗氧化产品中的应用,其特征在于具体步骤为:
将200 mg木聚糖溶于100 mL蒸馏水中,加入1.1 g CaCl2,用0.1 mol/L NaOH溶液调节pH至10.0,在60 ℃下反应90 min;反应结束后,浓缩,醇沉12 h,4000 r/min离心10 min取其沉淀,用无水乙醇洗涤至滤液中没有氯离子被检出,加入适量蒸馏水,旋转蒸发除去乙醇;蒸馏水透析24 h,浓缩,冷冻干燥得到木聚糖钙络合物,钙含量为7.35 mg/g;
所述木聚糖钙络合物在制备具有抗氧化作用的营养品、保健品或药物中的应用,包括在清除DPPH自由基、羟基自由基、ABTS自由基的营养品、保健品或药物中的应用。
2.根据权利要求1所述的应用,其特征在于:所述营养品、保健品或药物的剂型为片剂、颗粒剂、硬胶囊、软胶囊、口服液、粉剂、合剂、丸剂或滴丸,以及药学上可接受的载体或辅料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310608567.6A CN116874643A (zh) | 2023-05-27 | 2023-05-27 | 一种木聚糖钙络合物及其在抗氧化产品中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310608567.6A CN116874643A (zh) | 2023-05-27 | 2023-05-27 | 一种木聚糖钙络合物及其在抗氧化产品中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116874643A true CN116874643A (zh) | 2023-10-13 |
Family
ID=88257483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310608567.6A Pending CN116874643A (zh) | 2023-05-27 | 2023-05-27 | 一种木聚糖钙络合物及其在抗氧化产品中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116874643A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101720883A (zh) * | 2009-11-26 | 2010-06-09 | 山东龙力生物科技股份有限公司 | 低聚木糖作为钙吸收促进剂的应用 |
CN102964459A (zh) * | 2012-11-02 | 2013-03-13 | 华南理工大学 | 香菇多糖钙络合物及其制备方法与应用 |
CN109879980A (zh) * | 2019-03-06 | 2019-06-14 | 武汉轻工大学 | 一种米糠多糖金属络合物的制备方法及抗氧化剂 |
CN110584123A (zh) * | 2019-09-19 | 2019-12-20 | 桂林理工大学 | 一种木聚糖多糖铁复合物、制备方法及其应用 |
CN114573732A (zh) * | 2022-02-27 | 2022-06-03 | 桂林理工大学 | 一种具有益生作用的木聚糖锌络合物的制备方法及应用 |
-
2023
- 2023-05-27 CN CN202310608567.6A patent/CN116874643A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101720883A (zh) * | 2009-11-26 | 2010-06-09 | 山东龙力生物科技股份有限公司 | 低聚木糖作为钙吸收促进剂的应用 |
CN102964459A (zh) * | 2012-11-02 | 2013-03-13 | 华南理工大学 | 香菇多糖钙络合物及其制备方法与应用 |
CN109879980A (zh) * | 2019-03-06 | 2019-06-14 | 武汉轻工大学 | 一种米糠多糖金属络合物的制备方法及抗氧化剂 |
CN110584123A (zh) * | 2019-09-19 | 2019-12-20 | 桂林理工大学 | 一种木聚糖多糖铁复合物、制备方法及其应用 |
CN114573732A (zh) * | 2022-02-27 | 2022-06-03 | 桂林理工大学 | 一种具有益生作用的木聚糖锌络合物的制备方法及应用 |
Non-Patent Citations (1)
Title |
---|
XIA LI 等: "Optimization on preparation technology of xylan polysaccharides iron complex and its antioxidant activities", FOOD & MACHINERY, no. 3, 26 June 2020 (2020-06-26), pages 203 - 208 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2016940B1 (en) | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions | |
CN108752501B (zh) | 一种含有机酸盐的壳聚糖季铵盐及其制备方法和应用 | |
EP1478732B1 (en) | A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug | |
CN110105460B (zh) | 硒化羧甲基茯苓多糖及其制备方法及应用 | |
US11345761B2 (en) | Esterified selenium polysaccharide and preparation method and use therefor | |
WO2021007858A1 (zh) | 键合硒多糖及其制备方法和应用 | |
CN112250774B (zh) | 一种南瓜多糖铬硒配合物的制备方法及其制品和应用 | |
CN116874643A (zh) | 一种木聚糖钙络合物及其在抗氧化产品中的应用 | |
CN105859910B (zh) | 一种硒化低聚氨基多糖的制备方法 | |
CN1446790A (zh) | 药用级枸橼酸铁及其制备方法 | |
CN111280453B (zh) | 一种牛樟芝水不溶性膳食纤维的制备方法 | |
CN114053302A (zh) | 一种具有抗疲劳功效的复方食用菌多糖复合物的制备 | |
CN112300299A (zh) | 一种锌、钙多糖配合物的制备方法和应用 | |
CN1191371C (zh) | 易被体内吸收的蛋白化铁的制备方法以及利用它生产的保健食品 | |
CN112552422A (zh) | 玛咖多糖-锌(ⅱ)配合物的制备方法及其应用 | |
CN107417678B (zh) | 一氧化氮供体型二氢杨梅素衍生物及其制备和应用 | |
CN102002077A (zh) | 一种唾液酸-蛋氨酸锌新型偶联物、制备工艺及其应用 | |
CN110584123A (zh) | 一种木聚糖多糖铁复合物、制备方法及其应用 | |
CN116672355A (zh) | 一种羧甲基木聚糖锌络合物在保健药物或食品中的应用 | |
CN110563859B (zh) | 抗肝癌药物亚硒酸酯化壳聚糖铜的一锅合成法及应用 | |
CA2638081C (en) | Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions | |
CN104207142B (zh) | 一种补锌与排毒营养保健剂的制备方法 | |
CN108059652A (zh) | 一种利用蛋白酶解法制备的灰树花硒螯合肽 | |
CN106309372B (zh) | 一种牛骨多肽缓释剂及其制备方法 | |
RU2033160C1 (ru) | Способ производства витамина d3 -белкового препарата "видеин" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |